235 related articles for article (PubMed ID: 17512720)
1. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.
Duffy MJ; van Dalen A; Haglund C; Hansson L; Holinski-Feder E; Klapdor R; Lamerz R; Peltomaki P; Sturgeon C; Topolcan O
Eur J Cancer; 2007 Jun; 43(9):1348-60. PubMed ID: 17512720
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
Yu K; Fang X
Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
[TBL] [Abstract][Full Text] [Related]
3. Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.
Sawai K; Goi T; Kimura Y; Koneri K
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672639
[TBL] [Abstract][Full Text] [Related]
4. Novel tumor marker index using carcinoembryonic antigen and carbohydrate antigen 19-9 is a significant prognostic factor for resectable colorectal cancer.
Kamada T; Ohdaira H; Takahashi J; Aida T; Nakashima K; Ito E; Hata T; Yoshida M; Eto K; Suzuki Y
Sci Rep; 2024 Feb; 14(1):4192. PubMed ID: 38378762
[TBL] [Abstract][Full Text] [Related]
5. Screening and surveillance for hereditary colorectal cancer.
Kim HM; Kim TI
Intest Res; 2024 Apr; 22(2):119-130. PubMed ID: 38311713
[TBL] [Abstract][Full Text] [Related]
6. Correlation of the Pro-Inflammatory Cytokines IL-1β, IL-6, and TNF-α, Inflammatory Markers, and Tumor Markers with the Diagnosis and Prognosis of Colorectal Cancer.
Florescu DN; Boldeanu MV; Șerban RE; Florescu LM; Serbanescu MS; Ionescu M; Streba L; Constantin C; Vere CC
Life (Basel); 2023 Nov; 13(12):. PubMed ID: 38137862
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Significance of Hypomethylated
Shalmashi H; Safaei S; Zarredar H; Asvadi Kermani T; Hashemzadeh S; Mehdi Navaz A
Adv Biomed Res; 2023; 12():241. PubMed ID: 38073736
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Metastatic Colorectal Cancer Progression According to Reactive Oxygen Metabolite Derivative Levels.
Sawai K; Goi T; Kimura Y; Koneri K
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067221
[TBL] [Abstract][Full Text] [Related]
9. Revisiting ab initio carcinoembryonic antigen and CA19-9 tumor markers in colorectal carcinoma in association with anatomotopographic location and staging of disease.
Lerch M; Sengul D; Sengul I; Peteja M; Přibylová L; Gawel W; Pelikán A; Tomaskova H; Malý T; Janout V
Rev Assoc Med Bras (1992); 2023; 69(9):e20230627. PubMed ID: 37729380
[TBL] [Abstract][Full Text] [Related]
10. Exosomes in metastasis of colorectal cancers: Friends or foes?
Wu Z; Fang ZX; Hou YY; Wu BX; Deng Y; Wu HT; Liu J
World J Gastrointest Oncol; 2023 May; 15(5):731-756. PubMed ID: 37275444
[TBL] [Abstract][Full Text] [Related]
11. CEA dynamics for predicting response after anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.
Kang S; Kim SY; Hong YS; Kim TW; Choi KE; Kim MJ; Kim JE
Sci Rep; 2023 Apr; 13(1):6735. PubMed ID: 37185297
[TBL] [Abstract][Full Text] [Related]
12. The İmportance of tumor markers in patients undergoing resection for lung metastasis of colorectal carcinoma.
Ozgur GK; Tekneci AK; Bakali EH; Akcam TI; Ergonul AG; Ozdil A; Turhan K; Cakan A; Cagırıcı U
Clin Respir J; 2023 May; 17(5):429-438. PubMed ID: 37069584
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment Carcinoembryonic Antigen Level Serves as a Potential Biomarker to Guide Adjuvant Radiotherapy in pT4N+ Colon Cancer Patients.
Luo D; Zhang R; Yang Y; Li Q; Li X
J Oncol; 2023; 2023():4815996. PubMed ID: 36844877
[TBL] [Abstract][Full Text] [Related]
14. Choosing which in-hospital laboratory tests to target for intervention: a scoping review.
Podolsky E; Hudek N; McCudden C; Presseau J; Yanikomeroglu S; Brouwers M; Brehaut JC
Clin Chem Lab Med; 2023 Feb; 61(3):388-401. PubMed ID: 36410390
[TBL] [Abstract][Full Text] [Related]
15. A novel senescence-associated LncRNA signature predicts the prognosis and tumor microenvironment of patients with colorectal cancer: a bioinformatics analysis.
Huang E; Ma T; Zhou J; Ma N; Yang W; Liu C; Hou Z; Chen S; Zong Z; Zeng B; Li Y; Zhou T
J Gastrointest Oncol; 2022 Aug; 13(4):1842-1863. PubMed ID: 36092325
[TBL] [Abstract][Full Text] [Related]
16. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
[TBL] [Abstract][Full Text] [Related]
17. Potential of
Habiburrahman M; Wardoyo MP; Sutopo S; Rahadiani N
Mol Clin Oncol; 2022 Jul; 17(1):117. PubMed ID: 35747597
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer.
Dohmen J; Semaan A; Kobilay M; Zaleski M; Branchi V; Schlierf A; Hettwer K; Uhlig S; Hartmann G; Kalff JC; Matthaei H; Lingohr P; Holdenrieder S
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741223
[TBL] [Abstract][Full Text] [Related]
19. Potentials of long non-coding RNAs as biomarkers of colorectal cancer.
Lv Y; Wang Y; Zhang Z; Bao J; Su H
Clin Transl Oncol; 2022 Sep; 24(9):1715-1731. PubMed ID: 35581419
[TBL] [Abstract][Full Text] [Related]
20. Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and CEA as the Potential Prognostic Biomarkers for Colorectal Cancer.
Ming-Sheng F; Mei-Ling D; Xun-Quan C; Yuan-Xin H; Wei-Jie Z; Qin-Cong P
Can J Gastroenterol Hepatol; 2022; 2022():3109165. PubMed ID: 35028301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
